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Abstract 
 Patients that present with a periprosthetic joint infection in a single joint 
may have multiple prosthetic joints. The risk of these patients developing a 
subsequent infection in another prosthetic joint is unknown. Our purposes were (1) 
identify the risk of developing a subsequent infection in another prosthetic joint; 
and (2) describe the time span, and organism profile to the second prosthetic 
infection. We retrospectively identified 55 patients with periprosthetic joint 
infection who had another prosthetic joint in place at the time of presentation. 
Eleven of the 55 patients (20%) developed a periprosthetic joint infection in a 
second joint. The type of organism was the same as the first infection in four of 11 
patients (36%). The time to developing a second infection was 2.0 years (range, 0-
6.9 years). 
 
Keywords:  Multiple Periprosthetic Joint Infection; Hip Arthroplasty; Knee 
Arthroplasty; Risk of subsequent infection; Phenotypically Identical Infecting 
Organisms. 
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Introduction 
 Periprosthetic joint infection (PJI) is an important failure mechanism of 
implants after either primary or revision total joint arthroplasty (TJA)1-3. It occurs 
in approximately 0.2% to 2.5% of primary THAs or TKAs2,4-6. Revision THA or 
TKA carries an infection risk of 3.2% to 9%2,3. When PJI develops, an extensive 
burden is placed on the affected patient and the treating physician. PJI causes 
considerable increase in the cost of health care and increases the rate of morbidity 
and mortality2,7. 
 On occasion, patients presenting with developed PJI have multiple lower 
limb prosthetic joints. It is always a concern that the presence of any nidus of 
ongoing infection in the body can lead to PJI. Therefore, it is cause for concern 
that patients may develop PJI in coexisting, aseptic joints when another joint 
becomes infected. To mediate infections, surgeons use methods such as antibiotics, 
irrigation and debridement, and antibiotic spacers. In order to help curtail 
infection, patients are encouraged to take antibiotics before procedures that are 
considered high risk for inducing bacteremia, such as dental procedures. However, 
the role of these prophylactic antibiotics is a matter of controversy8,9. 
 Therefore, we had two objectives: (1) to identify the risk of developing an 
additional PJI in a coexisting prosthetic joint; and (2) to describe the time to 
additional infection and organism profile of the second prosthetic infection. 
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Patients and Methods 
 We used our joint infection database to identify patients that had confirmed 
diagnoses of PJI at our institute from 2000 to 2009. These patients were 
crossreferenced with our prospective joint arthroplasty database to identify all 
patients who had at least two primary arthroplasties (hip or knee) performed at 
this institution and later developed a PJI in at least one. We identified 55 patients. 
These patients averaged 63.4 years of age (range: 31-90 years) and 26 of the 55 
(47%) were male.  The average BMI of these 55 patients was 32.2 kg/m2 (95% CI: 
30.1-34.2).  Out of the 55 patients, 46 (84%) presented with pertinent 
comorbidities (Table 1). Seventeen (30.9%; 17/55%) patients developed a PJI 
within a four week period postoperatively, thus indicating an acute onset.  The 
remaining 38 (%) developed their first incident of PJI within 8.2 years.  Nine 
(16%) of these patients presented with ipsilateral implants, 37 (67%) were 
contralateral knees, 16 (29%) were contralateral hips, and nine (16%) were 
contralateral hip and knee. Five patients had three prosthetic joints and two 
patients had both hips and both knees replaced.  The total number of joints does 
not total 55 because of patients who presented with more than two joints replaced. 
These patients with three and four joints replaced constitute the discrepancy of the 
overall figure and the 55 patients noted (Table 1). Infection was defined as the 
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presence of a positive preoperative fluid or intraoperative tissue culture, presence 
of purulence, or elevated erythrocyte sedimentation rate, C-reactive protein, 
synovial white blood cell, and polymorphonuclear percentage10.  Follow-up for 
this study is defined as patients that suffered a single PJI while having multiple 
TJA in place, who subsequently returned for an additional infection to a second 
joint. In this case no patients were lost to follow-up; however, it is possible that 
patients retained services for an additional infection elsewhere.  No patients were 
recalled specifically for this study; all data was obtained from medical records.  
We had prior approval of our Institutional Review Board. 
 To ascertain the rate of infection in a prosthetic joint after development of 
PJI in the first joint, the joint infection database at this institution was again used 
to identify any subsequent infections in these patients. It was verified that the 
subsequent infection cases developed in prosthetic joints that had been replaced 
before the development of the first periprosthetic joint infections. 
 The nature of the second infection was analyzed by noting the duration 
between the initial infection and the subsequent infection, and determining the 
organism profile for each infection. Organisms of the two infections were 
considered identical if they were of identical species and had identical resistance 
profiles. 
6 
 
 To ascertain potential predictors of suffering multiple joint PJI in this group 
of patients, univariate statistical analysis was performed on potential variables 
(Table 1).   This included age, BMI, gender, systemic health, and status of joint 
replacements.  Systemic health was measured with the Deyo et al modification of 
the Charlson Index.11  A review of charts was also performed in attempts to 
identify specific comorbidities that may contribute to risk of subsequent additional 
joint PJI.  Statistical analysis consisted of a Student’s t-test for continuous 
variables and Chi-squared test for categorical variables.  Analysis was performed 
using PASW Statistics 18.0.0 (SPSS Incorporated, Chicago, IL). 
Results 
 Of the 55 patients who presented with multiple coexisting prosthetic joints, 
with PJI present in at least one, 11 patients (20%) subsequently developed PJI in a 
second coexisting prosthetic joint.  The second joint infection developed in 
contralateral knees in eight (73%) of the 11 patients, contralateral hips in two 
(18%) of the 11 patients, and ipsilateral hip and knee in one patient (9%) (Figure 
1).  The average BMI of these 11 patients was found to be 31.3 kg/m2, 
demonstrating no statistical difference when compared to that of the overall 
cohort.  When comparing specific comorbidities of the patients diagnosed with 
multiple infections versus those with a solitary infection no statistical difference 
exists.  However, when comparing the multiple versus single PJI groups, the 
7 
 
multiple PJI group had a greater median Charlson Index (4 versus 2.5; p=0.16).  
As well, the initial PJI incident was less likely to have occurred in the acute 
postoperative setting (less than four weeks) compared to the single PJI group 
(9.1% versus 36.4%; p=0.08) 
 Of these 11 patients that sustained multiple PJIs, four were diagnosed as 
having phenotypically identical organisms for both infections. For two of these 
patients, the presentation of PJI was simultaneous. The two remaining patients 
presented with the second joint infection at 4 months and 3.5 years, respectively 
(Figure 2). The time from presentation of the original PJI to the infection in the 
second joint averaged 2.0 years (range, 0-6.88 years). 
 
Discussion 
 Several studies have been performed to find the risk factors for infection 
after TJA to decrease the rate of this devastating complication6,8,9,12,13. 
Accordingly, several preventive measures have been recommended to decrease the 
rate of PJI8,9. However, the authors were unable to find any literature that 
addresses the risk of developing synchronous or metachronous PJI.   Therefore, we 
had two objectives: (1) to identify the risk of developing an additional PJI in a 
coexisting prosthetic joint; and (2) to describe the time to additional infection and 
organism profile of the second prosthetic infection. 
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 Our study has some limitations. First, this investigation is a retrospective 
review of a database; the data is input by clerks and as such is subject to clerical 
error and/or may be incomplete, rendering a lower yield of complete data set. 
Second, despite all efforts to capture all PJI in our institution during the study 
time, some patients may have sought medical attention at other institutions in the 
event of developing PJI. Finally, despite evaluating all data referring to diagnostic 
workup for PJI, some origin or nidus of infection that could have led to a 
subsequent PJI may have been missed. This would yield different results in the 
mechanism of infection, which is why we refrain ourselves from establishing such 
in the article. 
 We found that 55 patients presented with multiple coexisting prosthetic 
joints, in which at least one developed PJI. Eleven patients developed a PJI in a 
second coexisting prosthetic joint. Therefore, the relative risk of developing a 
synchronic or metachronic PJI is 20%. In patients who did not present with 
simultaneous PJI, the time of presentation for metachronic PJI averaged 2.71 
years. 
 This increased risk of developing another PJI appears excessively high 
compared even with the highest incidence of isolated PJI reported in the literature. 
In our cohort, all patients shared the same preoperative, intraoperative, and 
postoperative protocols (prophylactic antibiotic, laminar flow, personal protection 
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system, etc), similar hospital stay, and same postoperative rehabilitation regimen. 
The fact that some patients with multiple TJA only develop an isolated PJI and 
some develop multiple PJI may indicate a host compromise or a reoccurring 
exposure despite the similarities in preexisting condition and demographics 
between the multiple and single PJI groups.  While statistical significance was not 
achieved, the large difference in Charlson Index supports the reasoning that 
patients who developed multiple PJI have decreased general health contributing to 
multiple joint PJI.  Supporting this is the observation that a third of single PJI 
patients developed PJI within the acute postoperative period, while less than 10% 
of multiple PJI patients developed PJI in the acute postoperative period.  This 
points to a compromised immune system and lower overall health leading to PJI in 
the multiple PJI group while surgical contamination appears to be a major factor 
in the single PJI group.  This would suggest that the risk of multiple infections do 
not coincide with  presence of multiple joints but rather the associated traits and 
actions of the patient. 
 Four of the 11 patients (36%) with multiple PJI were diagnosed as having 
phenotypically identical infecting organisms for both joints (Figure 1); in two of 
these patients, the presentation was synchronic, suggesting a hematogenous mode 
of infection. In the other two metachronic PJI, host characteristics were most likely 
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the cause of multiple infections. In all four of these patients, the involved joints 
where contralateral.  
This evaluation shows that there is a high risk of developing multiple joint PJI 
when patients present with PJI in a single joint and multiple prosthetic joints.  It 
appears that the risk is elevated in immunocompromised patients suffering chronic 
or delayed PJI.  Future research is needed to confirm the risk factors identified 
here and develop methods for minimizing the risk of multiple joint PJI.  Regardless 
of the cause, it is evident that there is a significant risk of multiple joint PJI (20%) 
and therefore,  the surgeon should cautiously investigate any asymptomatic joints 
in the face of a single PJI, and alert the patient to the increased risk of subsequent 
PJI. 
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